616
Participants
Start Date
December 31, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
vilazodone
titration to 40 milligrams (mg) every day (qd) for 1 year
Eastside Comprehensive Medical Center, New York
The Medical Research Network, LLC, New York
Bioscience Research, LLC, Mount Kisco
Paramount Clinical Research, Bridgeville
Introspect of Buxmont, Colmar
Suburban Research Associates, Media
Neuroscience, Inc., Herndon
Capital Clinical Research Associates, Rockville
Dominion Clinical Research, Midlothian
Carman Research, Smyrna
Florida Clinical Research Center, LLC, Lady Lake
Clinical Neuroscience Solutions, Inc, Jacksonville
Sarkis Clinical Trials, Gainesville
Clinical Neuroscience Solutions, PA, Orlando
CNS Clinical Research Group, Coral Springs
Stedman Clinical Trials, Tampa
Gulfcoast Clinical Research, Fort Myers
Clinical Neuroscience Solutions, Memphis
North Coast Clinical Trials, Beachwood
North Star Medical Research, LLC, Middleburg Heights
Patient Priority Clinical Sites, LLC, Cincinnati
Davis Clinic, Indianapolis
Summit Research Network, Farmington
Capstone Clinical Research, Libertyville
Chicago Research Center, Chicago
Radiant Research, St Louis
Vince and Associates Clinical Research, Overland Park
IPS Research Company, Oklahoma City
FutureSearch Trials, Dallas
Croft Group Research Center, San Antonio
FutureSearch Trials, Austin
Radiant Research, Denver
Radiant Research, Las Vegas
Collaborative Neuroscience Network, Inc, Torrance
Pacific Clinical Research, Upland
Affiliated Research Institute, San Diego
Collaborative Neuroscience Network, Inc., Garden Grove
Neuropsychiatric Associates, Woodstock
Lead Sponsor
Forest Laboratories
INDUSTRY